Klinische Forschung Schwerin GmbH

Schwerin, Mecklenburg-Vorpommern 19055

1 studies enrolling now · 8 studies all time

What they study most

Cardiovascular Disease, Dyslipidemia, Gastroparesis, Menstrual Migraine, Migraine, Moderate Psoriasis, Obstructive Sleep Apnea, Plaque Psoriasis, Psoriasis, Psoriasis (PsO), Severe Psoriasis, Type2 Diabetes

Studies at this site

• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Recruiting now
• A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 — Completed
• Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis — Running, not enrolling
• Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Diabetic Gastroparesis Study 05 — Stopped early
• "Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early